TUBB3locvps

locvps  时间:2021-01-03  阅读:()
TableS1:Detailedclinico-pathologicalinformationforthePUMsAbbreviations:PM=primarymanagement,LBD=largestbasaldiameter,UH=ultrasoundheight,CBI=ciliarybodyinvolvement,EOE=extraocularextension,HPF=highpowerfields,Enuc=enucleation,PBT=protonbeamRXT,LR=localresection,N=no,Y=yes,N/A=notassessed,del=deletion,amp=amplification,M3=monosomy3*=fromaSNPdataSampleIDPUMtoMUM01PUM02(MUM03)PUMtoMUM05PUM04(MUM07)PUM05(MUM08)PUMtoMUM09PUMtoMUM10PUM08(MUM11)PUMtoMUM13PUMtoMUM17PUMtoMUM18PUM18(MUM21)AgeatPM645439696448666560675467GenderMaleMaleFemaleFemaleFemaleMaleMaleFemaleFemaleMaleMaleMaleTypeofPMEnucEnucEnucEnucEnucPBTEnucLR,EnucEnucPBTPBTEnucLBD(mm)15.
516.
618.
718.
918.
78.
716.
514.
3418.
516.
215.
2UH(mm)7.
52.
48.
389.
72.
237.
64.
33.
99.
414.
1CBINNNYNNNNYNNNEOENNNNNNNNY(Episclera)NNNEpithelioidCellsYYYYYYYYYYNRYClosedLoopsYYYYNNRYYNNRNRYMitoticCount(40HPF)516286NR10204NRNR52Chr.
3status*N/AHeterozygousdeletionsandROHN/AHeterozygousdeletionsandROHHeterozygousdeletionsandROHN/AN/AHeterozygousdeletionsandROHN/AN/AN/AHeterozygousdeletionsandROHChr.
8qstatus*N/APartialampN/AAmpAmpN/AN/AAmpN/AN/AN/AAmpTableS2:Detailedclinico-pathologicalinformationfortheMUMsAbbreviations:dia=diameter,NR=notreported,N=no,Y=yes,NA=notapplicable,del=deletion,amp=amplification,D3=disomy3,M3=monosomy3,MM=metastaticmelanoma*=fromaSNPdata**=timebetweenprimarydiagnosisandlastfollow-upSampleIDMUM01MUM03MUM05MUM07MUM08MUM09MUM10MUM11MUM13MUM17MUM18MUM21TypeofSampleLiverresectionLiverresectionLiverresectionLiverresectionLiverresectionLiverresectionLiverresectionLaparoscopicbiopsyLaparoscopicbiopsyLiverresectionLiverresectionLiverresectionLesionsize(mm)40x35x1316x15x1415x11x1037x36x6225x20x320india11x9x104india12india5x2x135x25x23NRLiverSegmentIVaVIII,IIIVIII,V,VIINRVIINANANRV,VINRCellTypeMixedMixedMixedMixedEpithelioidEpithelioidSpindleSpindleMixedMixedSpindleNRPigmentationNYYYYNNRNYYYNRChr.
3status*HeterozygousdeletionsandROHHeterozygousdeletionsandROHHeterozygousdeletionsandROHIsodisomyHeterozygousdeletionsandROHIsodisomyIsodisomyHeterozygousdeletionsandROHM3M3D3M3Chr.
8qstatus*AmpPartialampAmpAmpAmpAmpAmpAmpAmpAmpAmpAmpDeceasedYNYYYYYYYYNYCauseofDeathMM---MMMMMMMMMMMMMMMM---MMOverallSurvivalTime(years)5.
513.
4**4.
22.
72.
94.
43.
31.
98.
11.
211.
1**4.
3TableS3:Listof193geneswithCNVsidentifiedinPUM02,PUM04,PUM05,andPUM08GeneSymbolGeneSymbolGeneSymbolGeneSymbolGeneSymbolGeneSymbolGeneSymbolGeneSymbolAARSCENPTDUS2KLHDC4MBTPS1NUTF2SLC7A6TUBB3ACDCHMP1AEDC4KLHL36MC1ROSGIN1SLC7A6OSURAHPACSF3CHTF8ENKD1LCATMIR140PABPN1LSMG1P7USP10ADAD2CIRH1AESRP2LINC00304MIR1538PARD6ASNAI3VAC14AFG3L1PCLEC18AEXOSC6LINC00311MIR1972-1PDFSNAI3-AS1VILLAGRPCLEC18CFAM157CLOC100129697MIR1972-2PDPRSNORD111VPS4AANKRD11COG4FAM65ALOC100131303MIR26A1PDXDC2PSNORD111BVPS9D1APRTCOG8FAM92BLOC100287036MIR3155APFKFB3SNORD68VPS9D1-AS1ASB13COTL1FANCALOC100289580MIR3155BPIEZO1SNTB2WFDC1ATP2C2CPNE7FBXO31LOC100505942MIR4722PLA2G15SPATA2LWWP2ATP6V0D1CRISPLD2FUKLOC100506083MIR5093PLCD1SPATA33ZC3H18BANPCTCFGALNSLOC101927817MIR5189PRDM7SPG7ZCCHC14C16orf86CTRLGAS8LOC101928682MIR6773PRMT7SPIRE2ZDHHC1C16orf95CTU2GAS8-AS1LOC101928708MIR6775PSKH1ST3GAL2ZDHHC7CA5ACYB5BGFOD2LOC101928737MLYCDPSMB10TAF1CZFPM1CALML3CYBAHAS3LOC101928880MTSS1LRANBP10TANGO6ZNF276CALML3-AS1DBNDD1HSD11B2LOC102724467MVDRBM17TCF25ZNF469CALML5DDX19AHSDL1LOC339059NECAB2RLTPRTERF2ZNF778CBFA2T3DDX19BIL15RALOC399715NET1RNF166THAP11TableS4:Listof135geneswithCNVsidentifiedinallPUM-MUMpairsGeneSymbolGeneSymbolGeneSymbolGeneSymbolGeneSymbolGeneSymbolGeneSymbolGeneSymbolADAM6CYP11B2HGH1LYPD2MIR6849PUF60TMED10P1ZNF7ADCK5DENND3HSF1MAF1MIR6850PYCRLTMEM249ZNF707AGO2DGAT1JRKMAFAMIR6893RECQL4TONSLARCEEF1DKIAA0125MAFA-AS1MIR7112RHPN1TOP1MTARHGAP39EPPK1KIAA1875MAPK15MIR7641-2RHPN1-AS1TRAPPC9BAI1ETV5KIFC2MFSD3MIR937RNF5P1TSNARE1BOP1EXOSC4LINC00051MIR1268AMIR939RNU6-2TSTA3BREA2FAM83HLINC01300MIR1302-7MROH1RPL8VPS28C8orf31FAM83H-AS1LOC100133669MIR4472-1MROH5SCRIBZC3H3C8orf33FBXL6LOC100287098MIR4507MROH6SCRT1ZFP41C8orf82FOXH1LOC100288181MIR4537NAPRTSCXZNF16CCDC166GLI4LOC100507316MIR4538NRBP2SHARPINZNF250CDC42P3GMLLRRC14MIR4539OPLAHSLC39A4ZNF251CHRAC1GPAA1LRRC24MIR4664PARP10SLC45A4ZNF252PCOMMD5GPIHBP1LY6DMIR661PLECSLC52A2ZNF252P-AS1CPSF1GPR20LY6EMIR6845PPP1R16ASLURP1ZNF34CYC1GPTLY6HMIR6846PSCASPATC1ZNF517CYHR1GRINALY6KMIR6847PTK2THEM6ZNF623CYP11B1GSDMDLYNX1MIR6848PTP4A3TIGD5ZNF696TableS5:DetailedresultsofSNPanalysisandIHCforallMUMsassessedSampleGeneMUM01MUM05MUM07MUM08MUM10MUM11MUM17MUM18MUM21C-MYCCNamplificationamplificationamplificationamplificationamplificationamplificationamplificationamplificationamplificationAsCNampwAIampwAIampwAIampwAIampwAIampwAIampwAIampw/oAIampwAIIHC(nuclear)moderate50%moderate70%weak5%strong80%weak20%strong95%moderate40%moderate90%strong80%IHC(score)452727467BAP1CNunchangeddeletionunchangedunchangedunchangeddeletiondeletionunchangeddeletionAsCNAllelichomozygosityLOHAllelichomozygosityAllelichomozygosityAllelichomozygosityLOHLOHunchangedLOHIHC(nuclear)negativenegativenegativenegativenegativenegativenegativepositivenegativeAbbreviations:CN=copy-numberanalysis,AsCN=allele-specificcopy-numberanalysis,IHC=immunohistochemistry,amp=amplification,LOH=lossofheterozygosity,AI=allelicimbalanceFigureS1:OverviewofchromosomaldistributionofgeneCNVsinMUMs.
Top:Amplificationswerefoundonallidentifiedchromosomes,exceptforchr.
3.
Themostcommongeneamplificationsoccurredonchr.
8,followedbychr.
20,17,and19.
Manyamplifiedgeneswereseenin50%(6/12)orlesssampleswithinthecohort.
Bottom:Deletionswerelessfrequentandmainlyoccurredonchr.
3.
However,notmorethan8/12MUMsshowedthesamegenedeletion.
FigureS2:ComparisonofCNandAsCNanlysis.
OntheleftthechromosomaldistributionfortheCNVsidentifiedwithintheMUMsaredepictedforchr.
3.
OntherightthechromosomaldistributionfortheidentifiedAsCNwithinthecohortareshownforchr.
3.
MostlyregionswithnoamplificationordeletionbyCNanalysisshowregionsofhomozygosity(ROH)inAsCNanalysis.
.
FigureS3:VennDiagrams(VD)ofdetailedanalysisofthefivePUM-MUMpairs.
TheindividualVDsforeachpair(atthetopandbottom)revealinformationregardingthecountofalteredgenesbeinguniquetoMUM(green),uniquetoPUM(red),andaresharedbetweenbothpartnersofthepair(yellow,intersect).
VDscombiningthisinformation(middle)revealthatfortheMUMsnoCNVwassharedbymorethanthreesamples,135geneswerefoundinallfivepairs,and194CNVsweredetectedinfourPUMs.

ProfitServer折优惠西班牙vps,荷兰vps,德国vps,5折优惠,不限制流量

profitserver正在对德国vps(法兰克福)、西班牙vps(马德里)、荷兰vps(杜廷赫姆)这3处数据中心内的VPS进行5折优惠促销。所有VPS基于KVM虚拟,纯SSD阵列,自带一个IPv4,不限制流量,在后台支持自定义ISO文件,方便大家折腾!此外还有以下数据中心:俄罗斯(多机房)、捷克、保加利亚、立陶宛、新加坡、美国(洛杉矶、锡考克斯、迈阿密)、瑞士、波兰、乌克兰,VPS和前面的一样性...

ZJI韩国BGP+CN2服务器,440元起

ZJI又上新了!商家是原Wordpress圈知名主机商:维翔主机,成立于2011年,2018年9月启用新域名ZJI,提供中国香港、台湾、日本、美国独立服务器(自营/数据中心直营)租用及VDS、虚拟主机空间、域名注册等业务。本次商家新上韩国BGP+CN2线路服务器,国内三网访问速度优秀,适用8折优惠码,优惠后韩国服务器最低每月440元起。韩国一型CPU:Intel 2×E5-2620 十二核二十四线...

御云(RoyalYun):香港CN2 GIA VPS仅7.9元每月起,美国vps仅8.9/月,续费同价,可叠加优惠

御云怎么样?炎炎暑期即将来临,御云(royalyun)香港、美国服务器开启大特惠模式。御云是新成立的云服务提供商,主要提供香港、美国的云服务器,不久将开启虚拟主机业务。我们的香港和美国主机采用CN2 GIA线路。目前,香港cn2 gia vps仅7.9元每月起,美国vps仅8.9/月,续费同价,可叠加优惠,香港云服务器国内延迟一般在50ms左右,是搭建网站的最佳选择,但是请不要用于违法用途。点击进...

locvps为你推荐
租服务器租服务器是什么意思?虚拟主机代理紧急寻求好的虚拟主机代理商me域名.me域名和com的价值对比,懂的告诉我呀虚拟主机申请个人虚拟主机怎么申请?jsp虚拟空间JSP虚拟目录及虚拟路径的配置方法美国网站空间购买美国网站空间使用会不会麻烦呢,网站空间商个人网站备案如何从空间商到备案手机网站空间手机网页空间需要多大?100m虚拟主机100元虚拟主机大连虚拟主机上海未星网络科技有限公司是一家什么样的公司?
长沙虚拟主机 fc2新域名 上海域名注册 vps服务器 域名服务dns的主要功能为 域名备案中心 budgetvm smartvps 瓦工 kvmla t楼 秒解服务器 表单样式 godaddy域名优惠码 蜗牛魔方 100x100头像 qingyun 什么是刀片服务器 adroit 世界测速 更多